Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium (vol 101, pg 341, 2017)

Collapse authors list.
van der Wouden, CH, Cambon-Thomsen, A, Cecchin, E, Cheung, KC, Davila-Fajardo, CL, Deneer, VH, Dolzan, V, Ingelman-Sundberg, M, Jonsson, S, Karlsson, MO et al (show 15 more authors) , Kriek, M, Mitropoulou, C, Patrinos, GP, Pirmohamed, M ORCID: 0000-0002-7534-7266, Samwald, M, Schaeffeler, E, Schwab, M, Steinberger, D, Stingl, J, Sunder-Plassmann, G, Toffoli, G, Turner, RM ORCID: 0000-0002-7315-679X, van Rhenen, MH, Swen, JJ and Guchelaar, H-J (2017) Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium (vol 101, pg 341, 2017). CLINICAL PHARMACOLOGY & THERAPEUTICS, 102 (1). p. 152.

	Text UPGx CPT State of the Art.pdf - Author Accepted Manuscript Download (573kB)
	Text Wouden_et_al-2016-Clinical_Pharmacology_&_Therapeutics.pdf - Author Accepted Manuscript Download (2MB)
	Text Table_1.pdf - Author Accepted Manuscript Download (313kB)
	Text Table_2.pdf - Author Accepted Manuscript Download (295kB)
	Text Supplemental_Material.pdf - Author Accepted Manuscript Download (355kB)
	Image Figure_1.tif - Author Accepted Manuscript Download (349kB)
	Image Figure_2.tif - Author Accepted Manuscript Download (807kB)
	Image Figure_3.tif - Author Accepted Manuscript Download (864kB)
	Image Figure_4.tif - Author Accepted Manuscript Download (447kB)
	Image Figure_5.tif - Author Accepted Manuscript Download (465kB)
	Image Figure_6.tif - Author Accepted Manuscript Download (133kB)

Abstract

Clin. Pharmacol. Ther. 101, 341–358 (2017); doi:10.1002/cpt.602. On page 344, under the heading “Cleveland Clinic's Personalized Medication Program”, the gene drug pair reported as “HLA-B*1502-abacavir” should be “HLA-B*5701-abacavir”. In the first row of Table 1 on page 347, under the column heading “Drug-gene pairs…”, the drug-gene pair “HLA-B*1501/abacavir” should be “HLA-B*5701/abacavir”. In Table 2 on page 353, in the “Antiepileptic” row, under the “Clinically relevant genetic interaction” column, “HLA-B*5701” should be “HLA-B*1502”. The authors regret these errors and thank Dr. Francesco Rucci for bringing them to their attention.

Item Type:	Article
Uncontrolled Keywords:	Ubiquitous Pharmacogenomics Consortium
Depositing User:	Symplectic Admin
Date Deposited:	16 Aug 2017 09:15
Last Modified:	19 Jan 2023 06:57
DOI:	10.1002/cpt.725
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3009011